Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

vanoxerine

Known as: 1-(2 (bis(4-fluorophenyl)methoxy)ethyl)-4-(3-phenylpropyl)piperazine, 1-(2-(bis(p-fluorophenyl)methoxy)ethyl)-4-(3-phenylpropyl)piperazine, vanoxeamine 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Vanoxerine has been in clinical trials for Parkinsonism, depression and cocaine addiction but lacked efficacy. Although a potent… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Review
2012
Review
2012
Cocaine abuse is a serious health problem in many areas of the world, yet there are no proven effective medications for the… Expand
  • table I
  • table II
  • table III
  • table IV
  • table V
2010
2010
Cellular Electrophysiology of Vanoxerine. Introduction: There remains an unmet need for safe and effective antiarrhythmic drugs… Expand
2010
2010
Vanoxerine Terminates AF and AFL. Background: Vanoxerine produces potent block of cardiac hERG, sodium, and L‐type calcium… Expand
2008
2008
Drug abuse is a risk factor for neurological complications in HIV infection. Cocaine has been shown to exacerbate HIV-associated… Expand
1997
1997
In Mongolian gerbils, bilateral carotid occlusion (BCO) followed by reperfusion causes uniform destruction of the CA1 pyramidal… Expand
1996
1996
Fast cyclic voltammetry (FCV) was used to measure electrically stimulated monoamine efflux in the rat ventral lateral geniculate… Expand
1994
1994
Fast cyclic voltammetry (FCV) at carbon fibre microelectrodes was used to monitor 'real time' endogenous noradrenaline (NA… Expand
1993
1993
Each of 12 healthy male subjects received single oral doses of 100 mg vanoxerine (GBR 12909), a dopamine reuptake inhibitor with… Expand
1993
1993
The human pharmacokinetics of vanoxerine (GBR 12909) were studied in 14 normal subjects with a multiple-dose regimen. In a… Expand